NovoCure Ltd — Director's Dealing 2021

May 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2021-05-05

Reporting Person: LEUNG GABRIEL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-05	Ordinary Shares	M	1000	$31.45	Acquired	73045	Direct
2021-05-05	Ordinary Shares	S	1000	$199.67	Disposed	72045	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-05	Options to Buy Ordinary Shares	$31.45	M	1000	Disposed	2028-05-30	Ordinary Shares (1000.0)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.

F2: Fully vested as of the date hereof.